Unum Therapeutics Strengthens and Expands Leadership Team

NEXT STORY
BeiGene Announces Clinical Results from Three Posters on Zanubrutinib Presented at the 24th Congress of European Hematology Association (EHA)
PREV STORY
Oncology Venture provides financial details regarding its recent acquisition of additional ownership in dovitinib
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Biocartis Group NV: Results of the annual shareholders’ meeting held on 12 May 2017

   PRESS RELEASE: REGULATED INFORMATION12 May 2017, 17:40 CEST                                                            Results of the annual shareholders' ...

author_avatar
NASDAQ Market News

Zomedica Provides Product Development Update

ANN ARBOR, Mich., June 19, 2018 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (NYSE American:ZOM) ...

author_avatar
NASDAQ Market News

Five Prime Announces Cabiralizumab Phase 1a/1b Data Abstract Selected for Late Breaking Oral Presentation at the Society for Immunotherapy of Cancer (SITC) 32nd Annual Meeting

SOUTH SAN FRANCISCO, Calif., Oct. 11, 2017 (GLOBE NEWSWIRE) -- Five Prime Therapeutics, Inc. ...

author_avatar
NASDAQ Market News